Removes the expiration date on certain provisions relating to gender transition

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Hudson, Brad; House handler: N/A
Last action: 2026-01-27
Official status: Second Read and Referred S Families, Seniors and Health Committee
Effective date: 2026-08-28

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

2026-01-27 S238
Second Read and Referred S Families, Seniors and Health Committee
2026-01-07 S70
S First Read
2025-12-01 Missouri House of Representatives and Missouri Senate
Prefiled

Official Summary Text

The following summaries of this bill are available:

Print All Summaries

Introduced

Print

SB 1200 - Currently, a health care provider shall not knowingly prescribe or administer cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for children. This provision of law does not apply to those children who were prescribed or administered such drugs prior to August 28, 2023.

This prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on August 28, 2027. This act removes that expiration date. Additionally, the provision excluding those children already prescribed or administered the hormones or drugs prior to August 28, 2023, from the general prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on March 1, 2027.

This act is substantially similar to SB 75 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 249 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024).
SARAH HASKINS